From knowledge to practice in chronic cardiovascular disease: A long and winding road

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1738-1742

  Majumdar, Sumit R ^a   McAlister, Finlay A ^a,c   Furberg, Curt D ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ACE; angiotensin converting enzyme; heart failure; Heart Outcomes Prevention and Evaluation study; HF; HOPE; MI; myocardial infarction; randomized clinical trial; RCT

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEMOGRAPHY; DISEASE COURSE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; MEDICAL CARE; MEDICAL PRACTICE; OUTCOMES RESEARCH; OUTPATIENT CARE; PATIENT; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 2442503786     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.043     Document Type: Article

References (50)

1. Lamas G.A., Pfeffer M.A., Hamm P., Werthemer J., Rouleau J.L., Braunwald E. SAVE Investigators. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med. 327:1992;241-247
2. Stafford R.S., Radley D.C. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 41:2003;56-61
3. Soumerai S.B., Majumdar S.R., Lipton H.L. Evaluating and improving physician prescribing. Strom B. Pharmaco-epidemiology. 3rd edition:2000;483-503 John Wiley and Sons, Toronto
4. Mehta R.H., Montoye C.K., Gallogly M., et al. Improving quality of care for acute myocardial infarction The guidelines applied in practice (gap) initiative. JAMA. 287:2002;1269-1276
5. Ferguson T.B., Peterson E.D., Coombs L.P., et al. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery A randomized controlled trial. JAMA. 290:2003;49-56
6. Cleland J.G.F., Cohen-Solal A., Cosin Aguilar J., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme) An international survey. Lancet. 360:2002;1631-1639
7. McAlister F.A., Taylor L., Teo K.K., et al. CQIN Investigators. The treatment and prevention of coronary heart disease in Canada Do older patients receive efficacious therapies? J Am Geriatr Soc. 47:1999;811-818
8. Moore T.J. Deadly Medicine. 1995;Simon & Schuster, New York, NY
9. Bucher H.C., Guyatt G.H., Cook D.J., Holbrook A., McAlister F.A. Evidence-Based Medicine Working Group. Users' guides to the medical literature XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. JAMA. 282:1999;771-778
10. The Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey Programme - a survey on the quality of care among patients with heart failure in Europe. Part 2 Treatment. Eur Heart J. 24:2003;464-474
11. Cabana M., Rand C., Power N., et al. Why don't physicians follow clinical practice guidelines? JAMA. 282:1999;1458-1465
12. Guyatt G., Rennie D. Users' Guides to the Medical Literature A manual for evidence-based practice. 2002;AMA Press, Chicago, IL
13. Califf R.M., DeMets D.L. Principles from clinical trials relevant to clinical practice Part 1. Circulation. 106:2002;1015-1021
14. Clarke M., Chalmers I. Discussion sections in reports of controlled trials published in general medical journals. Islands in search of continents? JAMA. 280:1998;280-282
15. McAlister F.A. Applying evidence to patient care From black and white to shades of grey. Ann Intern Med. 138:2003;938-939
16. Naylor C.D., Chen E., Strauss B. Measured enthusiasm Does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med. 117:1992;916-921
17. Go A.S., Rao R.K., Dauterman K.W., Massie B.M. A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 108:2000;216-226
18. Jong P., Gong Y., Liu P.P., et al. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 108:2003;184-191
19. Majumdar S.R., Inui T.S., Gurwitz J.H., Gillman M.W., McLaughlin T.J., Soumerai S.B. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction. J Gen Intern Med. 16:2001;351-359
20. Ansari M., Alexander M., Tutar A., Bello D., Massie B.M. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 41:2003;62-68
21. Indridason O.S., Coffman C.J., Oddone E.Z. Is specialty care associated with improved survival of patients with congestive heart failure? Am Heart J. 145:2003;300-309
22. Adams A.S., Soumerai S.B., Lomas J., Ross-Degnan R. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care. 11:1999;187-192
23. Grover S.A., Lowensteyn I., Esrey K.L., Steinert Y., Joseph L., Abrahamowicz M. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ. 310:1995;975-978
24. Friedmann P.D., Brett A.S., Mayo-Smith M.F. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med. 124:1996;414-421
25. Houghton A.R., Cowley A.J. Why are angiotensin converting enzyme inhibitors underutilized in the treatment of heart failure by general practitioners? Int J Cardiol. 59:1997;7-10
26. Bungard T.J., Ghali W.A., McAlister F.A., et al. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. CMAJ. 165:2001;301-302
27. Protheroe J., Fahey T., Montgomery A.A., Peters T.J. The impact of patients' preferences on the treatment of atrial fibrillation Observational study of patient based decision analysis. BMJ. 320:2000;1380-1384
28. McAlister F.A., O'Connor A.M., Wells G., Grover S.A., Laupacis A. When should hypertension be treated? The different perspectives of Canadian patients and family physicians. CMAJ. 163:2000;403-408
29. Devereaux P.J., Anderson D.R., Gardner M.J., et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation Observational study. BMJ. 323:2001;1-7
30. McDonald H.P., Garg A.X., Haynes R.B. Interventions to enhance patient adherence to medication prescriptions Scientific review. JAMA. 288:2002;2868-2879
31. Berlowitz D.R., Ash A.S., Hickey E.C., et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 339:1998;1957-1963
32. Hyman D.J., Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 345:2001;479-486
33. Yarnall K.S.H., Pollak K.I., Krause K.M. Primary care Is there enough time for prevention? Am J Public Health. 93:2003;635-641
34. McAlister F.A., Lawson F.M.E., Teo K.K., Armstrong P.W. A systematic review of randomized trials of disease management programs in congestive heart failure. Am J Med. 110:2001;378-384
35. Majumdar S.R., McAlister F.A., Soumerai S.B. Synergy between publication and promotion Comparing adoption of new evidence in canada and the united states. Am J Med. 115:2003;467-472
36. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342:2000;145-153
37. Grimshaw J.M., Shirran L., Thomas R., et al. Changing provider behavior An overview of systematic reviews of interventions. Med Care. 39:(Suppl 2):2001;2-45
38. Davis D.A., Thomson M.A., Oxman A.D., Haynes R.B. Changing physician performance A systematic review of the effect of continuing medical education strategies. JAMA. 274:1995;700-705
39. Hennessy S., Bilker W.B., Zhou L., et al. Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA. 290:2003;1494-1499
40. Ayanian J.Z., Hauptman P.H., Guadagnoli E., Antman E.M., Pashos C.L., McNeil B.J. Knowledge and practice of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 331:1994;1136-1142
41. Ayanian J.Z., Guadagnoli E., McNeil B.J., Cleary P.D. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med. 157:1997;2570-2576
42. Kiefe C.I., Allison J.J., Williams O.D., Person S.D., Weaver M.T., Weissman N.W. Improving quality improvement using achievable benchmarks for physician feedback A randomized controlled trial. JAMA. 285:2001;2871-2879
43. Soumerai S.B., McLaughlin T.J., Gurwitz J.H., et al. Effect of local opinion leaders on quality of care for acute myocardial infarction A randomized controlled trial. JAMA. 279:1998;1358-1363
44. McColl A., Smith H., White P., Field J. General practitioners' perceptions of the route to evidence-based medicine A questionnaire survey. BMJ. 316:1998;361-365
45. Eccles M., McColl E., Steen N., et al. Effect of computerized evidence based guidelines on management of asthma and angina in adults in primary care A cluster randomized controlled trial. BMJ. 325:2002;941-948
46. Lomas J. Words without action? The production, dissemination, and impact of consensus recommendations. Annu Rev Public Health. 12:1991;41-65
47. Hunt D.L., Haynes R.B., Hanna S.E., Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes A systematic review. JAMA. 280:1998;1339-1346
48. Kaushal R., Shojania K.G., Bates D.W. Effects of computerized physician order entry and clinical decision support systems on medication safety A systematic review. Arch Intern Med. 163:2003;1409-1416
49. O'Connor A.M., Rostom A., Fiset V., et al. Decision aids for patients facing health treatment or screening decisions Systematic review. BMJ. 319:1999;731-734
50. Tsuyuki R.T., Johnson J.A., Teo K.K., et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management The study of cardiovascular risk intervention by pharmacists (scrip). Arch Intern Med. 162:2002;1149-1155